Passage Bio Stock (NASDAQ: PASG) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.00 / 256.40K |
Day Range | - - - |
52 Wk Range | 0.58 - 1.79 |
Market Cap | $42.06M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 3.39% |
Days to Cover | 8.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Passage Bio (NASDAQ:PASG) through any online brokerage.
Other companies in Passage Bio’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX) and OncoCyte (NASDAQ:OCX).
Passage Bio has a consensus price target of $8.00.
The stock price for Passage Bio (NASDAQ: PASG) is $0.681 last updated September 20, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Passage Bio.
Passage Bio’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Passage Bio.
Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.